Author

A. Doryab

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1

Frequent Co-Authors

C. Argyo· 1 shared C. Meyer-Schwickerath· 1 shared C. Morrone· 1 shared D. A. Bolukbas· 1 shared D. E. Wagner· 1 shared D. Goessl· 1 shared G. T. Stathopoulos· 1 shared L. Yang· 1 shared

Activity by Year

2020-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

C. Argyo

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Organ-restricted vascular delivery of nanoparticles for lung cancer therapy

D. A. Bolukbas, S. Datz, C. Meyer-Schwickerath, C. Morrone, A. Doryab, D. Goessl, M. Vreka, L. Yang, C. Argyo, S. H. van Rijt, M. Lindner, O. Eickelberg, T. Stoeger, O. Schmid, S. Lindstedt, , S. Meiners

This study introduces organ-restricted vascular delivery to enhance nanoparticle targeting to lung tumors, showing improved cellular uptake compared to systemic or intratracheal administration.

bioRxiv · Mar 5, 2020Pharmacology & Toxicology